Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP171647.RAKCjnZusjRx-pGvzHlxrQpUrnfj8goWfku8XzVJFhB6c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP171647.RAKCjnZusjRx-pGvzHlxrQpUrnfj8goWfku8XzVJFhB6c130_assertion type Assertion NP171647.RAKCjnZusjRx-pGvzHlxrQpUrnfj8goWfku8XzVJFhB6c130_head.
- NP171647.RAKCjnZusjRx-pGvzHlxrQpUrnfj8goWfku8XzVJFhB6c130_assertion description "[In pancreatic cancer, the NTR-1 mRNA levels were higher in advanced tumor stage (stages III and IV) than early tumor stage (stages I and II; P < 0.05), but no difference was found between well/moderately differentiated (grades 1 and 2) and poorly differentiated/undifferentiated cancers (grades 3 and 4; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171647.RAKCjnZusjRx-pGvzHlxrQpUrnfj8goWfku8XzVJFhB6c130_provenance.
- NP171647.RAKCjnZusjRx-pGvzHlxrQpUrnfj8goWfku8XzVJFhB6c130_assertion evidence source_evidence_literature NP171647.RAKCjnZusjRx-pGvzHlxrQpUrnfj8goWfku8XzVJFhB6c130_provenance.
- NP171647.RAKCjnZusjRx-pGvzHlxrQpUrnfj8goWfku8XzVJFhB6c130_assertion SIO_000772 10690540 NP171647.RAKCjnZusjRx-pGvzHlxrQpUrnfj8goWfku8XzVJFhB6c130_provenance.
- NP171647.RAKCjnZusjRx-pGvzHlxrQpUrnfj8goWfku8XzVJFhB6c130_assertion wasDerivedFrom befree-20140225 NP171647.RAKCjnZusjRx-pGvzHlxrQpUrnfj8goWfku8XzVJFhB6c130_provenance.
- NP171647.RAKCjnZusjRx-pGvzHlxrQpUrnfj8goWfku8XzVJFhB6c130_assertion wasGeneratedBy ECO_0000203 NP171647.RAKCjnZusjRx-pGvzHlxrQpUrnfj8goWfku8XzVJFhB6c130_provenance.